Home › NDC Lookup › RxCUI directory › RxCUI 1362211

Hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream [Analpram... — RxCUI 1362211

Name: Hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream [Anal… (RxCUI 1362211)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1362211 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1362211

Official nameHydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream [Analpram HC]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asAnalpram HC 2.5 % / 1 % (hydrocortisone acetate 2.5 % / pramoxine hydrochloride 1 % ) Rectal Cream; Analpram 2.5 % / 1 % Rectal Cream

FDA products mapped2

Package NDCs mapped4

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

This is a corticosteroid enema used specifically for ulcerative colitis that affects the lower part of your colon — the rectum and the left side. Rather than treating the whole bod...
What exactly is this enema treating — is it the same as regular colitis medicine?
Many people notice symptoms like diarrhea and bleeding improving within 3 to 5 days. That said, the actual healing of the colon lining often takes longer to show up — sometimes wee...
How long do I need to use it before it starts working?

📖 Read our full Hydrocortisone Rectal guide →

🕸️ Concept Web — How Hydrocortisone acetate 25 MG/ML / pramoxine hydr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream [Analpram HC] RxCUI 1362211 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Hydrocortisone 5492 IN
- Pramoxine 34347 IN
- Hydrocortisone / pramoxine 106955 MIN
- Hydrocortisone acetate 27197 PIN
- Pramoxine hydrochloride 57555 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Analpram HC 215264 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Hydrocortisone / pramoxine Rectal Cream 377728 SCDF
- Hydrocortisone acetate / pramoxine hydrochloride Rectal Cream 2649171 SCDFP
- Hydrocortisone / pramoxine Rectal Product 1164000 SCDG
- Hydrocortisone acetate / pramoxine hydrochloride Rectal Product 2661576 SCDGP
- Hydrocortisone / pramoxine Rectal Cream [Analpram HC] 1246573 SBDF
- Hydrocortisone acetate / pramoxine hydrochloride Rectal Cream [Analpram HC] 2655000 SBDFP
- Analpram HC Rectal Product 1246574 SBDG
- Rectal Cream 316975 DF
- +1 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream 1294025 SCD
- Hydrocortisone acetate 25 MG/ML 1234505 SCDC
- Pramoxine hydrochloride 10 MG/ML 828361 SCDC
- Hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML [Analpram HC] 1360955 SBDC

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream SCD · 1294025
Hydrocortisone acetate 25 MG/ML SCDC · 1234505
Pramoxine hydrochloride 10 MG/ML SCDC · 828361
Hydrocortisone / pramoxine Rectal Cream SCDF · 377728
Hydrocortisone acetate / pramoxine hydrochloride Rectal Cream SCDFP · 2649171
Hydrocortisone / pramoxine Rectal Product SCDG · 1164000
Hydrocortisone acetate / pramoxine hydrochloride Rectal Product SCDGP · 2661576

Brand-Name Concepts

Hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML [Analpram HC] SBDC · 1360955
Hydrocortisone / pramoxine Rectal Cream [Analpram HC] SBDF · 1246573
Hydrocortisone acetate / pramoxine hydrochloride Rectal Cream [Analpram HC] SBDFP · 2655000
Analpram HC Rectal Product SBDG · 1246574
Analpram HC BN · 215264

📦 FDA Products & Package NDCs

2 products · 4 package NDCs

4 package NDCs map to RxCUI 1362211 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
54766-0799-04	28.4 g in 1 TUBE, WITH APPLICATOR (54766-799-04)	Analpram HC	Sebela Pharmaceuticals Inc.	2015-08-07
54766-0799-65	12 TUBE, WITH APPLICATOR in 1 CARTON (54766-799-65) / 4 g i...	Analpram HC	Sebela Pharmaceuticals Inc.	2015-08-07
83107-0019-12	12 TUBE, WITH APPLICATOR in 1 CARTON (83107-019-12) / 4 g i...	Analpram HC	Legacy Pharma USA Inc.	2025-07-25
83107-0019-30	30 TUBE, WITH APPLICATOR in 1 CARTON (83107-019-30) / 4 g i...	Analpram HC	Legacy Pharma USA Inc.	2025-07-25

Observed labelers: Legacy Pharma USA Inc. (2) · Sebela Pharmaceuticals Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.